Table 5.
Effect on Life Expectancy at Age 40 Relative to Main Projectiona | ||||||
---|---|---|---|---|---|---|
2020 | 2030 | 2040 | ||||
Change in Procedure | Male | Female | Male | Female | Male | Female |
Use of Measured Data on Obesity at Age 25 | –0.038 | –0.061 | –0.067 | –0.095 | –0.059 | –0.103 |
No Future Growth in Obesity Among Initial Cohorts of 25- to 34-Year-Olds | 0.000 | 0.000 | 0.004 | 0.009 | 0.029 | 0.040 |
Use of Mortality Rates With No Control Except Age and Sex | 0.017 | 0.010 | 0.026 | 0.015 | 0.026 | 0.012 |
Use of Mortality Rates Without Inclusion of BMI at Age 25 | 0.026 | 0.056 | 0.095 | 0.164 | 0.199 | 0.289 |
No Exclusion Criteria Applied to Mortality Modeling | 0.046 | 0.072 | 0.099 | 0.141 | 0.145 | 0.202 |
Use of Alternative Series Translating Lung Cancer Into All-Cause Mortality | –0.067 | 0.012 | –0.173 | –0.107 | –0.322 | –0.360 |
aA positive value means that the alternative procedure resulted in a gain in projected life expectancy relative to the main procedure.